Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-Naïve and CYP17 Inhibitor-Naïve Patients: Follow-Up From the ARADES and ARAFOR Trials
European Urology Focus - Netherlands
doi 10.1016/j.euf.2017.01.015
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 1, 2018
Authors
Publisher
Elsevier BV